Novel distribution of the secretory leucocyte proteinase inhibitor in kidney
The secretory leucocyte proteinase inhibitor (SLPI) is a low molecular weight, tissue-specific inhibitor of, for example, elastase and cathepsin G, which also have antimicrobial capacity. SLPI has been localised to the respiratory, gastrointestinal and genital tracts, but so far not to the kidney. T...
Saved in:
Main Authors: | Sophie Ohlsson, Irena Ljungkrantz, Kjell Ohlsson, Mårten Segelmark, Jörgen Wieslander |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2001-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1080/09629350120102389 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Production of Secretory Leucocyte Protease Inhibitor (SLPI) in Human Pancreatic β-Cells
by: Max Nyström, et al.
Published: (1999-01-01) -
Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa
by: Max Nyström, et al.
Published: (2001-01-01) -
IgE-mediated histamine release from nasal mucosa is inhibited by SLPI (secretory leukocyte protease inhibitor) to the level of spontaneous release
by: U. Westin, et al.
Published: (1998-01-01) -
IA3, A Yeast Proteinase A Inhibitor, Is Intrinsically Unstructured in Solution
by: Terry Green, et al.
Published: (2002-01-01) -
Extracorporeal Circulation Causes Release of Neutrophil Gelatinase-Associated Lipocalin (NGAL)
by: Per Jönsson, et al.
Published: (1999-01-01)